[HTML][HTML] A review of current and novel therapies for idiopathic pulmonary fibrosis
R Rafii, MM Juarez, TE Albertson… - Journal of thoracic …, 2013 - ncbi.nlm.nih.gov
Idiopathic pulmonary fibrosis (IPF) is a progressively fibrotic interstitial lung disease that is
associated with a median survival of 2-3 years from initial diagnosis. To date, there is no …
associated with a median survival of 2-3 years from initial diagnosis. To date, there is no …
[PDF][PDF] A review of current and novel therapies for idiopathic pulmonary fibrosis
R Rafii, MM Juarez, TE Albertson… - Journal of Thoracic …, 2013 - cdn.amegroups.cn
Idiopathic pulmonary fibrosis (IPF) is a progressively fibrotic interstitial lung disease that is
associated with a median survival of 2-3 years from initial diagnosis. To date, there is no …
associated with a median survival of 2-3 years from initial diagnosis. To date, there is no …
[PDF][PDF] A review of current and novel therapies for idiopathic pulmonary fibrosis
R Rafii, MM Juarez, TE Albertson… - Journal of Thoracic …, 2013 - researchgate.net
Idiopathic pulmonary fibrosis (IPF) is a progressively fibrotic interstitial lung disease that is
associated with a median survival of 2-3 years from initial diagnosis. To date, there is no …
associated with a median survival of 2-3 years from initial diagnosis. To date, there is no …
[引用][C] A review of current and novel therapies for idiopathic pulmonary fibrosis
R Rafii - J. Thorac. Dis., 2013 - cir.nii.ac.jp
A review of current and novel therapies for idiopathic pulmonary fibrosis | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
[HTML][HTML] A review of current and novel therapies for idiopathic pulmonary fibrosis
R Rafii, MM Juarez, TE Albertson… - Journal of Thoracic …, 2013 - jtd.amegroups.org
Idiopathic pulmonary fibrosis (IPF) is a progressively fibrotic interstitial lung disease that is
associated with a median survival of 2-3 years from initial diagnosis. To date, there is no …
associated with a median survival of 2-3 years from initial diagnosis. To date, there is no …
A review of current and novel therapies for idiopathic pulmonary fibrosis
R Rafii, MM Juarez, TE Albertson… - Journal of thoracic …, 2013 - pubmed.ncbi.nlm.nih.gov
Idiopathic pulmonary fibrosis (IPF) is a progressively fibrotic interstitial lung disease that is
associated with a median survival of 2-3 years from initial diagnosis. To date, there is no …
associated with a median survival of 2-3 years from initial diagnosis. To date, there is no …
A review of current and novel therapies for idiopathic pulmonary fibrosis.
R Rafii, MM Juarez, TE Albertson… - Journal of Thoracic …, 2013 - europepmc.org
Idiopathic pulmonary fibrosis (IPF) is a progressively fibrotic interstitial lung disease that is
associated with a median survival of 2-3 years from initial diagnosis. To date, there is no …
associated with a median survival of 2-3 years from initial diagnosis. To date, there is no …
A review of current and novel therapies for idiopathic pulmonary fibrosis
R Rafii, MM Juarez, TE Albertson… - Journal of Thoracic …, 2013 - jtd.amegroups.org
Idiopathic pulmonary fibrosis (IPF) is a progressively fibrotic interstitial lung disease that is
associated with a median survival of 2-3 years from initial diagnosis. To date, there is no …
associated with a median survival of 2-3 years from initial diagnosis. To date, there is no …
A review of current and novel therapies for idiopathic pulmonary fibrosis.
R Rafii, MM Juarez, TE Albertson… - Journal of Thoracic …, 2013 - europepmc.org
Idiopathic pulmonary fibrosis (IPF) is a progressively fibrotic interstitial lung disease that is
associated with a median survival of 2-3 years from initial diagnosis. To date, there is no …
associated with a median survival of 2-3 years from initial diagnosis. To date, there is no …